Regulatory News / Reports and presentations / Financial calendar / The share / Shareholders / BASIC SHARE DATA / GOVERNANCE / Contact

Investor relations

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.

Observe Medical is listed on Euronext Oslo under OBSRV.

Link to prospectus here

 

Read our latest regulatory news

Observe Medical ASA: Notification of transaction by close associate to primary insider and disclosure of large shareholding

Oslo, 5 December 2024: Reference is made to the stock announcement published by Observe Medical ASA (the "Observe Medical") on 5 December 2024 regarding the final result of the subsequent offering and the partial conversion to shares of certain loans from Navamedic ASA ("Navamedic") to Observe Medical. Navamedic currently holds 4,222,727 shares in Observe Medical,…

Read more

Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 5 December 2024…

Read more

OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 4 December 2024…

Read more

Our newsfeed

READ ALL REGULATORY NEWS

Reports and presentations

Financial calendar

Quarterly reports and presentations

2024

2023

2022

2021

2020

2019

Annual reports

2024

2023

2022

2021

2020

Prospectus
Other presentations

2023

2022

2021

2020

  • 13 March 2024

    Second Half and Full Year Presentation - 2023

  • 30 April 2024

    Annual Report 2023

  • 24 May 2024

    Annual General Meeting

  • 30 August 2024

    First Half Year 2024 Report

The Share

Share performance

Shareholders

As at 12 January 2024

NameNumber of shares% of top 20% of total Country
1INGERØ REITEN INVESTMENT COMPANY AS

37,384,437

30.76%

19.61%

Norway
2

JPB AS

16,314,944

13.42%

8.56%

Norway
3

ELI AS

11,013,298

9.06%

5.78%

Norway
4

RO, LARS

6,000,000

4.94%

3.15%

Norway
5

GINNY INVEST AS

5,500,000

4.52%

2.88%

Norway
6

BJØRNTVEDT, VEGARD

5,024,141

4.13%

2.63%

Norway
7

SILVERCOIN INDUSTRIES AS

4,948,437

4.07%

2.60%

NORWAY

8

NAVAMEDIC ASA

4,222,727

3.47%

2.21%

Norway
9

LAPAS AS

3,468,311

2.85%

1.82%

Norway
10

BJØRNTVEDT, HARALD

3,200,121

2.63%

1.68%

Norway
11

SÆTHER, HERMOD ATLE

3,108,524

2.56%

1.63%

Norway
12

SKÅLVOLD EIENDOM AS

2,830,618

2.33%

1.48%

NORWAY

13

NORDNET BANK AB

2,580,060

2.12%

1.35%

SWEDEN

14

TAJ HOLDING AS

2,481,496

2.04%

1.30%

Norway
15

CAM AS

2,383,162

1.96%

1.25%

Norway
16

PHILIP HOLDING AS

2,380,000

1.96%

1.25%

Norway
17

WANGESTAD, ANDREAS

2,380,000

1.96%

1.25%

Norway
18

KRISTIANSEN, DAGFINNN HELGE

2,150,000

1.77%

1.13%

Norway
19

MP PENSJON PK

2,112,305

1.74%

1.11%

Norway
20

KUBERA AS

2,065,144

1.70%

1.08%

Norway
Total number owned by top 20

121,547,725

100.00%

63.74%

Total number of shares

190,685,204

Total number of shareholders

2,118

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

245 685 204

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

General meeting

2024

17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting

26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting

24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting

3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms

3 May 2024: Nomination Committee recommendation

3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel

2023

22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting 

1 November 2023: Attendance and proxy form to the extraordinary general meeting

Shareholders who receive the notice by post with ref. no. and pin code can log in here and register either registration, proxy or advance votes

Shareholders who receive the notice electronically must log in to investor services (click on events, general meeting) for their registration

1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023

26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting

26 May 2023: Represented List

5 May 2023:Notice of Annual General Meeting on 26 May 2023

5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023

5 May 2023: VPS – Investor services

5 May 2023: Nomination Committee recommendation

5 May 2023: Observe Medical – Report of salary and other remuneration to leading personnel

 

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee’s recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

Articles of association

Observe Medical ASA – Articles of association per 17 July 2024

 

Corporate Governance Principles
Corporate Governance Principles
Instructions for the Nomination Committee

Instructions for the Nomination Committee

IR contact

Jørgen Mann, Chief Executive Officer
+45 40 86 75 58 / jørgen.mann@observemedical.com

Johan M. Fagerli, Chief Financial Officer
+47 95 81 27 65 / johan.fagerli@observemedical.com

Sign up for the mailing list

Contact us

Observe Medical ASA
Dronning Eufemias gate 16
0191 Oslo, Norway
info@observemedical.com

Linkedin
© All Rights Reserved
Observe Medical ASA 2022